Cyclacel Pharma (CYCC) Hasn't Regained Compliance With Nasdaq Minimum Bid Price Requirement, to Request Hearing
Tweet Send to a Friend
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) (NASDAQ: CYCCP) (“Cyclacel” or the “Company”) today announced that on February 2, 2016, the Company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
